145 related articles for article (PubMed ID: 31668097)
1. Divergent
Lu Y; Wang L; Wang X; Yuan H; Zhao Y
Future Med Chem; 2019 Dec; 11(23):3015-3027. PubMed ID: 31668097
[No Abstract] [Full Text] [Related]
2. 2, 4, 5-Trideoxyhexopyranosides Derivatives of 4'-Demethylepipodophyllotoxin:
Lu Y; Zhu L; Cai R; Li Y; Zhao Y
Med Chem; 2022; 18(1):130-139. PubMed ID: 33222676
[TBL] [Abstract][Full Text] [Related]
3. Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis, and Antiproliferative Activity Evaluation.
Han HW; Lin HY; He DL; Ren Y; Sun WX; Liang L; Du MH; Li DC; Chu YC; Yang MK; Wang XM; Yang YH
Chem Biodivers; 2018 Nov; 15(11):e1800289. PubMed ID: 30194898
[TBL] [Abstract][Full Text] [Related]
4. Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties.
Shareef MA; Duscharla D; Ramasatyaveni G; Dhoke NR; Das A; Ummanni R; Srivastava AK
Eur J Med Chem; 2015 Jan; 89():128-37. PubMed ID: 25462233
[TBL] [Abstract][Full Text] [Related]
5. Biological evaluation and molecular modelling study of podophyllotoxin derivatives as potent inhibitors of tubulin polymerization.
Ma Y; Fang S; Li H; Han C; Lu Y; Zhao Y; Liu Y; Zhao C
Chem Biol Drug Des; 2013 Jul; 82(1):12-21. PubMed ID: 23786349
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticancer activity of dimeric podophyllotoxin derivatives.
Zi CT; Yang L; Xu FQ; Dong FW; Yang D; Li Y; Ding ZT; Zhou J; Jiang ZH; Hu JM
Drug Des Devel Ther; 2018; 12():3393-3406. PubMed ID: 30349193
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of podophyllotoxin congeners as tubulin polymerization inhibitors.
Kamal A; Srinivasa Reddy T; Polepalli S; Shalini N; Reddy VG; Subba Rao AV; Jain N; Shankaraiah N
Bioorg Med Chem; 2014 Oct; 22(19):5466-75. PubMed ID: 25131956
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and cytotoxicity of perbutyrylated glycosides of 4β-triazolopodophyllotoxin derivatives.
Zi CT; Liu ZH; Li GT; Li Y; Zhou J; Ding ZT; Hu JM; Jiang ZH
Molecules; 2015 Feb; 20(2):3255-80. PubMed ID: 25690288
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of cytotoxic activity of novel podophyllotoxin derivatives incorporating piperazinyl-cinnamic amide moieties.
Zhang X; Yang T; Jin X; Lin K; Dai X; Gao T; Huang G; Fan M; Ma L; Liu Z; Cao J
Bioorg Chem; 2022 Jun; 123():105761. PubMed ID: 35358823
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and antitumor activity of novel podophyllotoxin derivatives as potent anticancer agents.
Liu J; Cao B; Gao Y; Bai M; Mei X; Chen H; Jiang YG; Huang DJ
J Asian Nat Prod Res; 2013 Sep; 15(9):985-92. PubMed ID: 23859462
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 4α/4β-imidazolyl podophyllotoxin analogues as antitumor agents.
Shang H; Chen H; Zhao D; Tang X; Liu Y; Pan L; Cheng M
Arch Pharm (Weinheim); 2012 Jan; 345(1):43-8. PubMed ID: 21956645
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity of novel per-butyrylated glycosides of podophyllotoxin and its derivatives.
Zi CT; Yang D; Dong FW; Li GT; Li Y; Ding ZT; Zhou J; Jiang ZH; Hu JM
Bioorg Med Chem; 2015 Apr; 23(7):1437-46. PubMed ID: 25744190
[TBL] [Abstract][Full Text] [Related]
14. [Podophyllotoxin analogue with bicyclo[3.2.1]octane moiety annelated with indole: synthesis, molecular modeling, and biological testing].
Zefirov NA; Lavrushkina EA; Kuznetsov SA; Zefirova ON
Biomed Khim; 2019 Feb; 65(2):86-90. PubMed ID: 30950812
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, molecular docking and biological evaluation of 1-phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as novel potential tubulin assembling inhibitors.
Wang YT; Cai XC; Shi TQ; Zhang YL; Wang ZC; Liu CH; Zhu HL
Chem Biol Drug Des; 2017 Jul; 90(1):112-118. PubMed ID: 28032450
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, biological evaluation, and 3D-QSAR analysis of podophyllotoxin-dioxazole combination as tubulin targeting anticancer agents.
Wang ZZ; Sun WX; Wang X; Zhang YH; Qiu HY; Qi JL; Pang YJ; Lu GH; Wang XM; Yu FG; Yang YH
Chem Biol Drug Des; 2017 Aug; 90(2):236-243. PubMed ID: 28079286
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of d-ring modified acid hydrazide derivatives of podophyllotoxin and their anticancer studies as Tubulin inhibiting agents.
Nerella S; Kankala S; Paidakula S; Gavaji B
Bioorg Chem; 2020 Jan; 94():103384. PubMed ID: 31776036
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of novel aroylthiourea derivatives of podophyllotoxin.
Zhao Y; Wang C; Wu Z; Fang J; Zhu L
Invest New Drugs; 2012 Feb; 30(1):17-24. PubMed ID: 20697773
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of piperazine acetate podophyllotoxin ester derivatives targeting tubulin depolymerization as new anticancer agents.
Sun WX; Ji YJ; Wan Y; Han HW; Lin HY; Lu GH; Qi JL; Wang XM; Yang YH
Bioorg Med Chem Lett; 2017 Sep; 27(17):4066-4074. PubMed ID: 28757065
[TBL] [Abstract][Full Text] [Related]
20. Drugs that inhibit tubulin polymerization: the particular case of podophyllotoxin and analogues.
Desbène S; Giorgi-Renault S
Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):71-90. PubMed ID: 12678752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
